NOVAFERT

Novel Advances in Fertility Expertise in Latvia and Estonia. Project duration: 01.09.2024 – 31.08.2027.

NOVAFERT 
Project No.
EE-LV00149

Priority 2. Jointly and smartly growing businesses 

Overview

Project partnership:

  • Celvia CC AS
  • Rīga Stradiņš University (Rīgas Stradiņa Universitāte)

Duration: 01.09.2024 – 31.08.2027

Total budget: 590 237.50 EUR

ERDF contribution: 472 190.00 EUR

Contact person: Kristel Rose,
[email protected]

Project Objective:

The project aims to jointly develop two molecular diagnostic tests for:

  • Female infertility
  • Male infertility

These tests will support precision medicine, improving:

  • Diagnostic accuracy and treatment efficiency for infertile couples.
  • The likelihood of successful treatment outcomes.
  • The reduction of inherited disorders in offspring.

Key Activities:

  • Addressing ethical considerations related to reproductive genetic testing.
  • Establishing a study biobank to support reproductive diagnostics.
  • Developing prototypes for both female and male infertility tests.
  • Validating the diagnostic tests to ensure reliability and effectiveness.
  • Providing guidelines for genetic counselling, supporting healthcare professionals and patients.

Expected Results:

  • Two validated molecular diagnostic tests for infertility treatment.
  • A study biobank to facilitate ongoing reproductive research.
  • Ethically sound and scientifically backed guidelines for genetic counselling.
  • Improved precision medicine solutions for infertility treatment.
  • Enhanced collaboration in reproductive health research across project partners.

Loomise kuupäev: 19.03.2025

open graph image